UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549


                                    FORM 8-K


                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


                        Date of Report: FEBRUARY 13, 2006


                              LISKA BIOMETRY, INC.
             (Exact name of registrant as specified in its chapter)


         FLORIDA                        333-94265                061562447
         -------                        ---------                ---------
(State or other jurisdiction     (Commission File Number)      (IRS Employer
of incorporation)                                            Identification No.)

                                 100 MAIN STREET
                           DOVER, NEW HAMPSHIRE 03820
                           --------------------------
               (Address of principal executive offices) (Zip Code)


                                 1-603-540-0828
                                 --------------
          (Telephone number, including area code, of agent for service)




Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

|_|   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 23 0.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240. 14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240. 13e-4(c))



INFORMATION TO BE INCLUDED IN THE REPORT




                                       1
<PAGE>


LISKA BIOMETRY, INC. is referred to hereafter as "the Company," "we," or "our."


Item 1.01 Entry into a Material Definitive Agreement;

On February 13, 2006, Liska Biometry, Inc. (the "Company") entered into a
Definitive Share Exchange Agreement whereby the Company has agreed to purchase
all of the outstanding securities of Digital Card Systems, Inc. ("Digital
Card"). In consideration for all of the shares of Digital Card, the Company will
issue 25,000,000 shares of common stock. The closing will not take place until
certain conditions, terms and financing are completed and met.


ITEM 9.01 Financial Statements and Exhibits

      (c) Index of Exhibits.

Exhibit
Number   Description
-------  -----------

10.1     Securities Exchange Agreement between the Company and Digital Card
         Systems, Inc.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


Date: February 13, 2006

Liska Biometry, Inc.

By /s/ Chris LeClerc
Chris LeClerc
President and Director


                                INDEX TO EXHIBITS

Exhibit No.
-----------

10.1  Securities Exchange Agreement between the Company and Digital Card
      Systems, Inc.





                                       2
{"company-data": {"conformed-name": "LISKA BIOMETRY INC", "cik": "0001102065", "assigned-sic": "9995", "irs-number": "061562447", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-94265", "film-number": "06609096"}, "business-address": {"street1": "6066 VINEYARD DRIVE", "city": "OTTAWA", "state": "A6", "zip": "K1C 2M5", "phone": "613-837-1909"}, "mail-address": {"street1": "6066 VINEYARD DRIVE", "city": "OTTAWA", "state": "A6", "zip": "K1C 2M5"}, "former-company": [{"former-conformed-name": "FTLA INC", "date-changed": "20020220"}, {"former-conformed-name": "FLORAN INTERNATIONAL INC", "date-changed": "20010403"}, {"former-conformed-name": "3045 CORP", "date-changed": "19991229"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

                        Date of Report: FEBRUARY 13, 2006

                              LISKA BIOMETRY, INC.
             (Exact name of registrant as specified in its chapter)

         FLORIDA                        333-94265                061562447
         -------                        ---------                ---------
(State or other jurisdiction     (Commission File Number)      (IRS Employer
of incorporation)                                            Identification No.)

                                 100 MAIN STREET
                           DOVER, NEW HAMPSHIRE 03820
                           --------------------------
               (Address of principal executive offices) (Zip Code)

                                 1-603-540-0828
                                 --------------
          (Telephone number, including area code, of agent for service)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

|_|   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 23 0.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240. 14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240. 13e-4(c))

INFORMATION TO BE INCLUDED IN THE REPORT

                                       1
LISKA BIOMETRY, INC. is referred to hereafter as "the Company," "we," or "our."

Item 1.01 Entry into a Material Definitive Agreement;

On February 13, 2006, Liska Biometry, Inc. (the "Company") entered into a
Definitive Share Exchange Agreement whereby the Company has agreed to purchase
all of the outstanding securities of Digital Card Systems, Inc. ("Digital
Card"). In consideration for all of the shares of Digital Card, the Company will
issue 25,000,000 shares of common stock. The closing will not take place until
certain conditions, terms and financing are completed and met.

ITEM 9.01 Financial Statements and Exhibits

      (c) Index of Exhibits.

Exhibit
Number   Description
-------  -----------

10.1     Securities Exchange Agreement between the Company and Digital Card
         Systems, Inc.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date: February 13, 2006

Liska Biometry, Inc.

By /s/ Chris LeClerc
Chris LeClerc
President and Director

                                INDEX TO EXHIBITS

Exhibit No.
-----------

10.1  Securities Exchange Agreement between the Company and Digital Card
      Systems, Inc.

                                       2